GLENMARK PHARMACEUTICALS LTD. - Glenmark announces the Discovery and Initiation of IND-enabling studies of a novel bi-specific monoclonal antibody targeting CD38
08 Jan 2016
Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated January 08, 2016 titled "Glenmark announces the Discovery and Initiation of IND-enabling studies of a novel bi-specific monoclonal antibody targeting CD38".
Source:
BSE India